Arteris, Inc. (NASDAQ:AIP - Get Free Report) CFO Nicholas B. Hawkins sold 1,730 shares of Arteris stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $8.02, for a total value of $13,874.60. Following the completion of the sale, the chief financial officer now directly owns 166,428 shares of the company's stock, valued at $1,334,752.56. This trade represents a 1.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Arteris Stock Up 1.0%
Shares of AIP traded up $0.08 during midday trading on Monday, hitting $8.01. The stock had a trading volume of 285,413 shares, compared to its average volume of 205,142. The company has a 50 day simple moving average of $6.89 and a two-hundred day simple moving average of $8.60. Arteris, Inc. has a twelve month low of $5.46 and a twelve month high of $12.64. The firm has a market cap of $336.24 million, a price-to-earnings ratio of -9.21 and a beta of 1.37. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.17 and a quick ratio of 1.17.
Wall Street Analyst Weigh In
A number of brokerages recently commented on AIP. Rosenblatt Securities reaffirmed a "buy" rating and set a $14.00 price objective on shares of Arteris in a research note on Wednesday, May 21st. Northland Securities lifted their target price on Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Wednesday, February 19th.
Read Our Latest Research Report on AIP
Institutional Trading of Arteris
Hedge funds and other institutional investors have recently modified their holdings of the company. US Bancorp DE increased its position in shares of Arteris by 29.0% in the fourth quarter. US Bancorp DE now owns 5,702 shares of the company's stock valued at $58,000 after acquiring an additional 1,283 shares during the last quarter. American Century Companies Inc. increased its position in Arteris by 6.0% during the fourth quarter. American Century Companies Inc. now owns 30,357 shares of the company's stock worth $309,000 after buying an additional 1,731 shares during the last quarter. EntryPoint Capital LLC increased its position in Arteris by 14.0% during the fourth quarter. EntryPoint Capital LLC now owns 19,814 shares of the company's stock worth $202,000 after buying an additional 2,430 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in Arteris by 4.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 78,690 shares of the company's stock worth $802,000 after buying an additional 3,298 shares during the last quarter. Finally, Wells Fargo & Company MN increased its position in Arteris by 38.9% during the fourth quarter. Wells Fargo & Company MN now owns 13,192 shares of the company's stock worth $134,000 after buying an additional 3,694 shares during the last quarter. Institutional investors and hedge funds own 64.36% of the company's stock.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.